About
Scope & Aims
Editorial office
Editorial board
Ethical standards and procedures
Abstracting and indexing
Contact
Articles & Issues
Current issue
Articles in press
Archive
For Authors
General rules
Ethics in publishing
Guide for authors
Templates
Publication charge
For Reviewers
Our reviewers
Ethics in publishing
Guide for reviewers
Books and Events
Books
Events
ORIGINAL PAPER
Prevalence estimates of sarcopenia in community-dwelling older adults in Northern Nigeria according to revised European and Asian reference criteria
1
Department of Physiotherapy, Faculty of Allied Health Sciences, Bayero University Kano, Kano, Nigeria
2
Department of Physiotherapy, Federal Medical Centre, Azare, Nigeria
3
Department of Physiotherapy, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Submission date: 2020-10-24
Acceptance date: 2020-11-24
Publication date: 2022-12-19
Physiother Quart. 2022;30(4):65-71
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The study aim was to estimate the prevalence of sarcopenia in community-dwelling Nigerian older adults using the Asian Working Group for Sarcopenia (AWGS) and the revised European Working Group on Sarcopenia in Older People (EWGSOP2) references.
Methods:
A total of 767 community-dwelling older adults aged 60 years were recruited for the study. Sarcopenia was defined in accordance with the AWGS and EWGSOP2 references.
Results:
As for the AWGS reference, 24.4% (95% CI: 21.4–27.6) of older adults had sarcopenia and the prevalence was significantly similar between men and women (p = 0.18); whereas with the EWGSOP2 reference, 36.2% were classified as having sarcopenia and the prevalence was significantly higher in men (p < 0.001). The agreement between the AWGS and EWGSOP2 criteria in estimating the prevalence of sarcopenia was moderate (κ = 0.591), with EWGSOP2 showing higher sensitivity (0.882). In accordance with the 2 references, the multivariable logistic regression showed that age was consistently associated with increased odds of sarcopenia, whereas female gender, muscle strength, and physical performance were significantly associated with decreased odds of sarcopenia in older adults (p < 0.001).
Conclusions:
The EWGSOP2 reference, compared with the AWGS reference, is more likely to identify older individuals with sarcopenia. Both references showed that muscle strength and physical performance were associated with a decreased risk of sarcopenia. Clinicians may use the EWGSOP2 reference criteria for early diagnosis and management of sarcopenia in older adults.
The study aim was to estimate the prevalence of sarcopenia in community-dwelling Nigerian older adults using the Asian Working Group for Sarcopenia (AWGS) and the revised European Working Group on Sarcopenia in Older People (EWGSOP2) references.
Methods:
A total of 767 community-dwelling older adults aged 60 years were recruited for the study. Sarcopenia was defined in accordance with the AWGS and EWGSOP2 references.
Results:
As for the AWGS reference, 24.4% (95% CI: 21.4–27.6) of older adults had sarcopenia and the prevalence was significantly similar between men and women (p = 0.18); whereas with the EWGSOP2 reference, 36.2% were classified as having sarcopenia and the prevalence was significantly higher in men (p < 0.001). The agreement between the AWGS and EWGSOP2 criteria in estimating the prevalence of sarcopenia was moderate (κ = 0.591), with EWGSOP2 showing higher sensitivity (0.882). In accordance with the 2 references, the multivariable logistic regression showed that age was consistently associated with increased odds of sarcopenia, whereas female gender, muscle strength, and physical performance were significantly associated with decreased odds of sarcopenia in older adults (p < 0.001).
Conclusions:
The EWGSOP2 reference, compared with the AWGS reference, is more likely to identify older individuals with sarcopenia. Both references showed that muscle strength and physical performance were associated with a decreased risk of sarcopenia. Clinicians may use the EWGSOP2 reference criteria for early diagnosis and management of sarcopenia in older adults.
REFERENCES (29)
1.
Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:21; doi: 10.1186/s40200-017-0302-x.
2.
Schaap LA, van Schoor NM, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. J Gerontol A Biol Sci Med Sci. 2018;73(9):1199–1204; doi: 10.1093/gerona/glx245.
3.
Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlögl M, Staehelin HB, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26(12):2793–2802; doi: 10.1007/s00198-015-3194-y.
4.
Dos Santos L, Cyrino ES, Antunes M, Santos DA, Sardinha LB. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J Cachexia Sarcopenia Muscle. 2017;8(2):245–250; doi: 10.1002/jcsm.12160.
5.
De Buyser SL, Petrovic M, Taes YE, Toye KRC, Kaufman J-M, Lapauw B, et al. Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing. 2016;45(5):602–608; doi: 10.1093/ageing/afw071.
6.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423; doi: 10.1093/ageing/afq034.
7.
Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101; doi: 10.1016/j.jamda.2013.11.025.
8.
Kim M, Won CW. Sarcopenia in Korean community-dwelling adults aged 70 years and older: application of screening and diagnostic tools from the Asian Working Group for Sarcopenia 2019 update. J Am Med Dir Assoc. 2020;21(6):752–758; doi: 10.1016/j.jamda.2020.03.018.
9.
Makizako H, Nakai Y, Tomioka K, Taniguchi Y. Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: a systematic review and meta-analysis. Phys Ther Res. 2019;22(2):53–57; doi: 10.1298/ptr.R0005.
10.
Lera L, Albala C, Sánchez H, Angel B, Hormazabal MJ, Márquez C, et al. Prevalence of sarcopenia in community-dwelling Chilean elders according to an adapted version of the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. J Frailty Aging. 2017;6(1):12–17; doi: 10.14283/jfa.2016.117.
11.
Su Y, Hirayama K, Han T-F, Izutsu M, Yuki M. Sarcopenia prevalence and risk factors among Japanese community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med. 2019;8(3):291; doi: 10.3390/jcm8030291.
12.
Dodds RM, Granic A, Davies K, Kirkwood TBL, Jagger C, Sayer AA. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study. J Cachexia Sarcopenia Muscle. 2017;8(2):229–237; doi: 10.1002/jcsm.12157.
13.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31; doi: 10.1093/ageing/afy169.
14.
Du Y, Wang X, Xie H, Zheng S, Wu X, Zhu X, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109; doi: 10.1186/s12902-019-0432-x.
15.
Foley RN, Wang C, Ishani A, Collins AJ, Murray AM. Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol. 2007;27(3):279–286; doi: 10.1159/000101827.
16.
Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014;14(Suppl. 1):15–28; doi: 10.1111/ggi.12220.
17.
Murphy RA, Ip EH, Zhang Q, Boudreau RM, Cawthon PM, Newman AB, et al. Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2014;69(6):751–758; doi: 10.1093/gerona/glt131.
18.
Kim H, Suzuki T, Kim M, Kojima N, Yoshida Y, Hirano H, et al. Incidence and predictors of sarcopenia onset in community-dwelling elderly Japanese women: 4-year follow-up study. J Am Med Dir Assoc. 2015;16(1):85.e1–85.e8; doi: 10.1016/j.jamda.2014.10.006.
19.
Yang L, Yao X, Shen J, Sun G, Sun Q, Tian X, et al. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol. 2020;130:110798; doi: 10.1016/j.exger.2019.110798.
20.
Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2012;67(1):48–55; doi: 10.1093/gerona/glr035.
21.
Zengin A, Jarjou LM, Prentice A, Cooper C, Ebeling PR, Ward KA. The prevalence of sarcopenia and relationships between muscle and bone in ageing West-African Gambian men and women. J Cachexia Sarcopenia Muscle. 2018;9(5):920–928; doi: 10.1002/jcsm.12341.
22.
Adebusoye LA, Ogunbode AM, Olowookere OO, Ajayi SA, Ladipo MM. Factors associated with sarcopenia among older patients attending a geriatric clinic in Nigeria. Niger J Clin Pract. 2018;21(4):443–450; doi: 10.4103/njcp.njcp_374_17.
23.
Stewart A, Marfell-Jones M, Olds T, De Ridder H. International standards for anthropometric assessment. Lower Hutt: International Society for the Advancement of Kinanthropometry; 2011.
24.
MacDermid J, Solomon G, Fedorczyk J, Valdes K. Clinical assessment recommendations, 3rd ed. Impairment-based conditions. Mount Laurel: American Society of Hand Therapists; 2015.
25.
Bohannon RW, Wang Y-C. Four-meter gait speed: normative values and reliability determined for adults participating in the NIH Toolbox study. Arch Phys Med Rehabil. 2019;100(3):509–513; doi: 10.1016/j.apmr.2018.06.031.
26.
Pang BWJ, Wee S-L, Lau LK, Jabbar KA, Seah WT, Ng DHM, et al. Prevalence and associated factors of sarcopenia in Singaporean adults – the Yishun study. J Am Med Dir Assoc. 2021;22(4):885.e1–885.e10; doi: 10.1016/j.jamda.2020.05.029.
27.
Lee JSW, Auyeung T-W, Kwok T, Lau EMC, Leung P-C, Woo J. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology. 2007;53(6):404–410; doi: 10.1159/000107355.
28.
Yamada M, Nishiguchi S, Fukutani N, Tanigawa T, Yukutake T, Kayama H, et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc. 2013;14(12):911–915; doi: 10.1016/j.jamda.2013.08.015.
29.
Yoo S-Z, No M-H, Heo J-W, Park D-H, Kang J-H, Kim SH, et al. Role of exercise in age-related sarcopenia. J Exerc Rehabil. 2018;14(4):551–558; doi: 10.12965/jer.1836268.134.
| eISSN: | 2544-4395 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
